These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

268 related items for PubMed ID: 12504835

  • 1. ADMA and oxidative stress are responsible for endothelial dysfunction in hyperhomocyst(e)inemia: effects of L-arginine and B vitamins.
    Sydow K, Schwedhelm E, Arakawa N, Bode-Böger SM, Tsikas D, Hornig B, Frölich JC, Böger RH.
    Cardiovasc Res; 2003 Jan; 57(1):244-52. PubMed ID: 12504835
    [Abstract] [Full Text] [Related]

  • 2. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase, is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia.
    Böger RH, Bode-Böger SM, Sydow K, Heistad DD, Lentz SR.
    Arterioscler Thromb Vasc Biol; 2000 Jun; 20(6):1557-64. PubMed ID: 10845872
    [Abstract] [Full Text] [Related]

  • 3. Asymmetric dimethyl-L-arginine (ADMA): a possible link between homocyst(e)ine and endothelial dysfunction.
    Stühlinger MC, Stanger O.
    Curr Drug Metab; 2005 Feb; 6(1):3-14. PubMed ID: 15720202
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke.
    Yoo JH, Lee SC.
    Atherosclerosis; 2001 Oct; 158(2):425-30. PubMed ID: 11583722
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
    Sydow K, Hornig B, Arakawa N, Bode-Böger SM, Tsikas D, Münzel T, Böger RH.
    Vasc Med; 2004 May; 9(2):93-101. PubMed ID: 15521698
    [Abstract] [Full Text] [Related]

  • 11. Consequences of hyperhomocyst(e)inemia on vascular function in atherosclerotic monkeys.
    Lentz SR, Malinow MR, Piegors DJ, Bhopatkar-Teredesai M, Faraci FM, Heistad DD.
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2930-4. PubMed ID: 9409278
    [Abstract] [Full Text] [Related]

  • 12. Oral vitamin B(12) and high-dose folic acid in hemodialysis patients with hyper-homocyst(e)inemia.
    Manns B, Hyndman E, Burgess E, Parsons H, Schaefer J, Snyder F, Scott-Douglas N.
    Kidney Int; 2001 Mar; 59(3):1103-9. PubMed ID: 11231366
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Hyperhomocyst(e)inemia and MTHFR C677T genotypes in patients with central retinal vein occlusion.
    Weger M, Stanger O, Deutschmann H, Temmel W, Renner W, Schmut O, Semmelrock J, Haas A.
    Graefes Arch Clin Exp Ophthalmol; 2002 Apr; 240(4):286-90. PubMed ID: 11981642
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Homocysteine and asymmetric dimethylarginine in relation to B vitamins in elderly people.
    Fabian E, Kickinger A, Wagner KH, Elmadfa I.
    Wien Klin Wochenschr; 2011 Aug; 123(15-16):496-501. PubMed ID: 21833599
    [Abstract] [Full Text] [Related]

  • 18. [Impact of adding folic acid, vitamin B(12) and probucol to standard antihypertensive medication on plasma homocysteine and asymmetric dimethylarginine levels of essential hypertension patients].
    Wu CJ, Wang L, Li X, Wang CX, Ma JP, Xia XS.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2012 Dec; 40(12):1003-8. PubMed ID: 23363713
    [Abstract] [Full Text] [Related]

  • 19. Hyperhomocyst(e)inemia induces multiorgan damage.
    Miller A, Mujumdar V, Shek E, Guillot J, Angelo M, Palmer L, Tyagi SC.
    Heart Vessels; 2000 Dec; 15(3):135-43. PubMed ID: 11289502
    [Abstract] [Full Text] [Related]

  • 20. Randomized placebo-controlled trial assessing a treatment strategy consisting of pravastatin, vitamin E, and homocysteine lowering on plasma asymmetric dimethylarginine concentration in mild to moderate CKD.
    Nanayakkara PW, Kiefte-de Jong JC, ter Wee PM, Stehouwer CD, van Ittersum FJ, Olthof MR, Teerlink T, Twisk JW, van Guldener C, Smulders YM.
    Am J Kidney Dis; 2009 Jan; 53(1):41-50. PubMed ID: 18786751
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.